Literature DB >> 6776906

Effect of treatment of malignant disease on growth in children.

N K Griffin, J Wadsworth.   

Abstract

The growth of 95 children with malignant disease was studied over a 3- or 4-year period, and compared with the growth of normal children matched for age and sex by calculation of the standard deviation score. The mean standard deviation score of the children with leukaemia fell in the first year of treatment, and thereafter showed little change, remaining below the normal. This effect was related to cranial and craniospinal irradiation, but not to age or duration of chemotherapy. The loss in eventual height attained was small and does not suggest any long-term interference with growth hormone production.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6776906      PMCID： PMC1627054          DOI： 10.1136/adc.55.8.600

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  8 in total

1.  The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases.

Authors:  J M Tanner; H Lejarraga; N Cameron
Journal:  Pediatr Res       Date:  1975-08       Impact factor: 3.756

2.  Growth retardation in children after megavoltage irradiation of the spine.

Authors:  J C Probert; B R Parker; H S Kaplan
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

3.  Letter: Radiation and pituitary function in children.

Authors:  C Dacou-Voutetakis; S Haidas; L Zannos-Mariolea
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

4.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-12       Impact factor: 3.791

5.  The effect of varying doses of cerebral irradiation on growth hormone production in childhood.

Authors:  S M Shalet; C G Beardwell; D Pearson; P H Jones
Journal:  Clin Endocrinol (Oxf)       Date:  1976-05       Impact factor: 3.478

6.  Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood.

Authors:  S M Shalet; C G Beardwell; I A MacFarlane; P H Jones; D Pearson
Journal:  Acta Endocrinol (Copenh)       Date:  1977-04

7.  Pituitary function after treatment of intracranial tumours in children.

Authors:  S M Shalet; C G Beardwell; P H Morris-Jones; D Pearson
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

8.  Growth hormone deficiency after treatment of acute leukaemia in children.

Authors:  S M Shalet; C G Beardwell; P H Jones; D Pearson
Journal:  Arch Dis Child       Date:  1976-07       Impact factor: 3.791
  8 in total
  7 in total

1.  Spinal growth after irradiation for Wilm's tumour.

Authors:  P Scheibel-Jost; J Pfeil; F U Niethard; B Fromm; E Willich; H Kuttig
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

2.  Effect of treatment of malignant disease on growth in children.

Authors:  S M Shalet; D A Price
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

3.  Height and lymphoblastic leukaemia.

Authors:  J Broomhall; R May; J S Lilleyman; R D Milner
Journal:  Arch Dis Child       Date:  1983-04       Impact factor: 3.791

4.  Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia.

Authors:  C P Sainsbury; R G Newcombe; I A Hughes
Journal:  Arch Dis Child       Date:  1985-09       Impact factor: 3.791

5.  When are we diagnosing growth hormone deficiency?

Authors:  S M Herber; R D Milner
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

6.  The comprehensive assessment of health status in survivors of childhood cancer: application to high-risk acute lymphoblastic leukaemia.

Authors:  D Feeny; A Leiper; R D Barr; W Furlong; G W Torrance; P Rosenbaum; S Weitzman
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

Review 7.  Abnormalities of growth and gonadal function in children treated for malignant disease: a review.

Authors:  S M Shalet
Journal:  J R Soc Med       Date:  1982-08       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.